Overcoming “RSV identity crisis,” Moderna announced data for its investigational mRNA-1083 vaccine, BWC0977 effort to target drug-resistant pathogens, and more this week from Contagion.
Canada’s Prison Needle Exchange Program: Reducing Hepatitis C at a Profit
World Hepatitis Day: Where Do We Go From Here?
Investigational Hepatitis D Therapy Well-Tolerated, Safe for Chronic Disease at Week 48
Vaccine Equality vs Equity with Dr. Jacinda Abdul-Mutakabbir
Hepatitis C and Homelessness: Assessing Risk Factors
Global Hepatitis C Rates Persist Despite Curative Treatments